Corteva, Inc. reported a strong first quarter for 2025, with organic sales increasing 3% to $4.61 billion, despite a 2% decrease in GAAP net sales to $4.42 billion. The company achieved a 15% increase in operating EBITDA, reaching $1.19 billion, and operating EPS grew 27% to $1.13. This performance was driven by rising demand for differentiated technology and a focus on cost discipline.
The Seed segment's net sales declined 2% to $2.71 billion, but saw a 3% price increase, particularly in North America, reflecting strong demand for its technology. Seed operating EBITDA rose 13% to $842 million, benefiting from price execution, net cost and productivity benefits, and improved net royalty. The Crop Protection segment's net sales also slipped 2% to $1.71 billion, but volume increased 5% due to demand for new products and biologicals, leading to a 22% jump in operating EBITDA to $377 million.
Corteva reaffirmed its full-year 2025 guidance, expecting net sales between $17.2 billion and $17.6 billion, operating EBITDA between $3.6 billion and $3.8 billion, and operating EPS between $2.70 and $2.95 per share. The company also reiterated its plan to repurchase approximately $1.0 billion of shares in 2025. Management indicated that the direct cost impact from tariffs in 2025 is expected to be manageable at about $50 million and is not impacting the full-year guidance range.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.